The PPARA/RXR and FXR and PXR/RXR activation pathways were also identified in BPS-treated preadipocytes and they have all been shown to modulate adipogenesis, lipid metabolism or obesity [42, 49–52]. The gene discussed is NR1I2; the disease is Obesity.